User profiles for Hanne Flinstad Harbo

Hanne Flinstad Harbo

Department of Neurology, Oslo University Hospital and University of Oslo
Verified email at medisin.uio.no
Cited by 15790

Environmental risk factors in multiple sclerosis

M Pugliatti, HF Harbo, T Holmøy… - Acta Neurologica …, 2008 - Wiley Online Library
Objectives – Multiple sclerosis (MS) likely results from an interaction between genetic and
exogenous factors. While genetics shapes the overall population MS susceptibility, observed …

[HTML][HTML] Genetic pleiotropy between multiple sclerosis and schizophrenia but not bipolar disorder: differential involvement of immune-related gene loci

OA Andreassen, HF Harbo, Y Wang… - Molecular …, 2015 - nature.com
Converging evidence implicates immune abnormalities in schizophrenia (SCZ), and recent
genome-wide association studies (GWAS) have identified immune-related single-nucleotide …

Altered ovarian function and cardiovascular risk factors in valproate-treated women

…, AJ Pakarinen, J van Parys, J Rättyä, HF Harbo… - The American journal of …, 2001 - Elsevier
PURPOSE: Polycystic ovaries and menstrual disturbances seem to be common among
women taking valproate for epilepsy. The purpose of the present study was to assess the …

[HTML][HTML] Blood neurofilament light concentration at admittance: a potential prognostic marker in COVID-19

…, L Heggelund, K Blennow, H Zetterberg, HF Harbo - Journal of …, 2021 - Springer
Objective To test the hypotheses that blood biomarkers for nervous system injury, serum
concentrations of neurofilament light chain protein (NfL) and glial fibrillary acidic protein (GFAp) …

Marked differences in prevalence of multiple sclerosis between ethnic groups in Oslo, Norway

C Smestad, L Sandvik, T Holmoy, HF Harbo… - Journal of …, 2008 - Springer
Objectives Oslo, the capital of Norway, has a high prevalence of multiple sclerosis (MS). In
recent decades there has been substantial immigration to Oslo from Asia, the Middle East and …

Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic …

…, T Holmøy, T Berge, KM Myhr, HF Harbo… - Journal of Neurology …, 2023 - jnnp.bmj.com
Introduction The effect of disease-modifying therapies (DMT) on vaccine responses is
largely unknown. Understanding the development of protective immunity is of paramount …

[HTML][HTML] The genetic architecture of human brainstem structures and their involvement in common brain disorders

…, L Flyckt, B Franke, O Frei, B Gelao, HF Harbo… - Nature …, 2020 - nature.com
Brainstem regions support vital bodily functions, yet their genetic architectures and involvement
in common brain disorders remain understudied. Here, using imaging-genetics data …

[HTML][HTML] Symptoms of fatigue and depression is reflected in altered default mode network connectivity in multiple sclerosis

…, D Alnæs, MK Beyer, LT Westlye, HF Harbo - PLoS …, 2019 - journals.plos.org
Background Fatigue and depression are frequent and often co-occurring symptoms in multiple
sclerosis (MS). Resting-state functional magnetic resonance imaging (rs-fMRI) represents …

Long-term valproate treatment induces changes in ovarian morphology and serum sex steroid hormone levels in female Wistar rats

E Taubøll, JIT Isojärvi, HF Harbo, AJ Pakarinen… - Seizure, 1999 - Elsevier
Long-term valproate treatment is associated with polycystic ovaries and endocrine disorders
in women with epilepsy. The mechanisms responsible for these effects are unknown, but …

[HTML][HTML] Assessment of cognitive function, structural brain changes and fatigue 6 months after treatment of neuroborreliosis

…, H Reiso, KJ Bjuland, AH Pripp, HF Harbo… - Journal of …, 2023 - Springer
Background Complete recovery after adequately treated neuroborreliosis is common, but
studies report that some patients experience persistent symptoms like self-reported cognitive …